Your session is about to expire
← Back to Search
Gradual Reduction Program for Smokeless Tobacco Cessation
N/A
Waitlist Available
Led By Devon Noonan, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Study Summary
This trialseeks to learn how to best help firefighters quit smokeless tobacco, by asking them to talk about their needs in focus groups. 40 firefighters will give insights to create a tailored cessation program.
Who is the study for?
This trial is for professional firefighters and first responders in North Carolina who are 18 or older, have used smokeless tobacco daily for the past year, and have access to a smartphone. It's not open to those under 18, non-firefighters/first responders, infrequent users of smokeless tobacco, or without smartphone access.Check my eligibility
What is being tested?
The study aims to develop a mobile text/chat cessation program tailored for firefighters wanting to quit smokeless tobacco. Participants will be divided into two groups: one will receive the gradual reduction intervention via mobile messages; the other group won't get this support (control group).See study design
What are the potential side effects?
Since this trial involves behavioral interventions with no medications involved, there are no direct medical side effects expected from participating. However, participants may experience psychological effects such as stress or anxiety during their attempt to quit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of firefighters who stated intervention changed smokeless tobacco use as measured by questionnaire
Percent of firefighters who stated intervention made them think about quitting as measured by questionnaire
Percent of firefighters who stated intervention was useful as measured by questionnaire
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: #EnufSnuff.TXT- First ResponderExperimental Treatment1 Intervention
Participants in this group will receive a mobile gradual smokeless tobacco reduction intervention
Group II: Enough Snuff InterventionActive Control1 Intervention
Participants in this group will receive tobacco cessation materials
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
#EnufSnuff.TXT- First Responder
2022
N/A
~60
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,093 Total Patients Enrolled
2 Trials studying Smokeless Tobacco Cessation
1,167 Patients Enrolled for Smokeless Tobacco Cessation
Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,009 Total Patients Enrolled
2 Trials studying Smokeless Tobacco Cessation
636 Patients Enrolled for Smokeless Tobacco Cessation
Devon Noonan, PhDPrincipal InvestigatorDuke University
2 Previous Clinical Trials
636 Total Patients Enrolled
2 Trials studying Smokeless Tobacco Cessation
636 Patients Enrolled for Smokeless Tobacco Cessation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not used any type of chewing tobacco or snuff in the past year, and you are not currently using it every day in the past month.You have been using smokeless tobacco every day for the past year and still use it daily within the past month.
Research Study Groups:
This trial has the following groups:- Group 1: #EnufSnuff.TXT- First Responder
- Group 2: Enough Snuff Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger